Company

Spark Therapeutics, Inc.

Spark Therapeutics develops gene therapy treatments for genetic diseases using adeno-associated viral vectors.

About

Established in 2013 and based in Philadelphia, US, Spark Therapeutics develops a gene therapy platform for discovering treatments for genetic diseases. The company uses adeno-associated viral (AAV) vectors in its investigational research.

1Funding rounds

3Investors

Sign in to see more

Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.

Sign in